|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 92 No. 4 (August 15), 1998:
pp. 1091-1096
RAPID COMMUNICATION
Familial Essential Thrombocythemia Associated With One-Base
Deletion in the 5 -Untranslated Region of the
Thrombopoietin Gene
Takeshi Kondo,
Mihiro Okabe,
Masayoshi Sanada,
Mitsutoshi Kurosawa,
Sachiko Suzuki,
Masanobu Kobayashi,
Masuo Hosokawa, and
Masahiro Asaka
From the Third Department of Internal Medicine and the Laboratory of
Pathology, Cancer Institute, Hokkaido University School of Medicine,
Sapporo, Hokkaido, Japan; and the Department of Hematology, Niigata
City General Hospital, Niigata-shi, Niigata Prefecture, Japan.
Familial essential thrombocythemia (ET) is inherited in an
autosomal-dominant manner. This finding implies that familial ET may
arise as a consequence of a mutation(s) that activates platelet production. In 1994, the thrombopoietin (TPO) gene was
isolated and cloned. The TPO-TPO receptor, encoded for by the
c-mpl gene, are essential regulators of thrombopoiesis.
Alterations of TPO or c-Mpl thus may constitute a pathogenic event
leading to familial ET. In a case of familial ET presented in our
institute, serum TPO levels were significantly elevated in affected
members of the family as compared with nonaffected members. Moreover,
we identified a one-base deletion in the 5 -untranslated region of the
TPO gene in affected but not in nonaffected family members. In
vitro experiments showed that the identified mutation increased TPO
production. Based on our findings, we propose that this region of the
TPO gene may play a crucial role in regulating TPO expression. Our results strongly suggest that the identified mutation leads to
familial ET.
© 1998 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
B. J. Lannutti, A. Epp, J. Roy, J. Chen, and N. C. Josephson
Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis
Blood,
February 19, 2009;
113(8):
1778 - 1785.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cazzola
Molecular basis of thrombocytosis
Haematologica,
May 1, 2008;
93(5):
646 - 648.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Liu, R. Kralovics, Z. Rudzki, B. Grabowska, A. S. Buser, D. Olcaydu, H. Gisslinger, R. Tiedt, P. Frank, K. Okon, et al.
A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family
Haematologica,
May 1, 2008;
93(5):
706 - 714.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Teofili, R. Foa, F. Giona, and L. M. Larocca
Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients?
Haematologica,
February 1, 2008;
93(2):
169 - 172.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Teofili, F. Giona, M. Martini, T. Cenci, F. Guidi, L. Torti, G. Palumbo, A. Amendola, R. Foa, and L. M. Larocca
Markers of Myeloproliferative Diseases in Childhood Polycythemia Vera and Essential Thrombocythemia
J. Clin. Oncol.,
March 20, 2007;
25(9):
1048 - 1053.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Skoda
The Genetic Basis of Myeloproliferative Disorders
Hematology,
January 1, 2007;
2007(1):
1 - 10.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. I. Schafer
Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia
Blood,
June 1, 2006;
107(11):
4214 - 4222.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. R. Moliterno, D. M. Williams, L. I. Gutierrez-Alamillo, R. Salvatori, R. G. Ingersoll, and J. L. Spivak
Mpl Baltimore: A thrombopoietin receptor polymorphism associated with thrombocytosis
PNAS,
August 3, 2004;
101(31):
11444 - 11447.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Ravid
Activating mutation in the c-MPL gene and FET
Blood,
June 1, 2004;
103(11):
3998 - 3999.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Ding, H. Komatsu, A. Wakita, M. Kato-Uranishi, M. Ito, A. Satoh, K. Tsuboi, M. Nitta, H. Miyazaki, S. Iida, et al.
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin
Blood,
June 1, 2004;
103(11):
4198 - 4200.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. I. Schafer
Thrombocytosis
N. Engl. J. Med.,
March 18, 2004;
350(12):
1211 - 1219.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Spivak
Polycythemia vera: myths, mechanisms, and management
Blood,
December 15, 2002;
100(13):
4272 - 4290.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Mesa, C. A. Hanson, C.-Y. Li, S.-Y. Yoon, S. V. Rajkumar, G. Schroeder, and A. Tefferi
Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia
Blood,
May 13, 2002;
99(11):
4131 - 4137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cazzola and R. C. Skoda
Translational pathophysiology: a novel molecular mechanism of human disease
Blood,
June 1, 2000;
95(11):
3280 - 3288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Ghilardi and R. C. Skoda
A Single-Base Deletion in the Thrombopoietin (TPO) Gene Causes Familial Essential Thrombocythemia Through a Mechanism of More Efficient Translation of TPO mRNA
Blood,
August 15, 1999;
94(4):
1480 - 1482.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. D. Nimer
Essential Thrombocythemia: Another "Heterogeneous Disease" Better Understood?
Blood,
January 15, 1999;
93(2):
415 - 416.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. N. Harrison, R. E. Gale, S. J. Machin, and D. C. Linch
A Large Proportion of Patients With a Diagnosis of Essential Thrombocythemia Do Not Have a Clonal Disorder and May Be at Lower Risk of Thrombotic Complications
Blood,
January 15, 1999;
93(2):
417 - 424.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
